All in all, the ChIP data provided insight that a small number of nucleolar proteins are preferentially enriched in metastatic breast cancer cells at the rDNA with RPA194, thereby potentially impacting RNA Pol I activity. This evidence concerns the gene POLR1A and breast cancer.